Congress moves to strip vaccine makers' liability shield, exposing them to unlimited lawsuits

What it does

This bill eliminates the liability shield that currently protects vaccine manufacturers and administrators from lawsuits over vaccine injuries. It allows people to sue vaccine makers and administrators directly in state or federal court for damages from vaccine-related injuries or deaths, and repeals key sections of the National Vaccine Injury Compensation Program (NVICP) that previously limited such lawsuits. It also excludes COVID-19 vaccines from federal emergency-use liability protections.

Why we flagged it

The bill's core function is to remove legal protections for vaccine manufacturers and dismantle the no-fault compensation system, shifting liability risk entirely to manufacturers and opening them to unlimited civil litigation. This is fundamentally a deregulation of vaccine liability law.

• Section 5 amends the definition of 'covered countermeasure' to explicitly exclude COVID-19 vaccines from federal emergency-use liability protections. This is substantively unrelated to the NVICP reform and appears designed to retroactively expose COVID-19 vaccine manufacturers to litigation.

What the text implies

• Retroactive liability exposure: The bill's effective date ('beginning on the date of enactment') may expose manufacturers to claims for injuries that occurred years ago under the old liability shield, creating massive tail liability and potential bankruptcy risk for vaccine makers.
• Vaccine price inflation: Manufacturers will likely increase vaccine prices substantially to offset unlimited liability risk, reducing affordability and access for uninsured and underinsured populations.

The full analysis lists 5 implications of this text.

Who stands to gain

Plaintiff's personal injury law firms; Litigation finance companies; Insurance companies (through increased premiums)